SCHEDULE: BCLS Fund III Holds 9.8% Stake in Heartflow

BCLS Fund III Investments, LP has reported a beneficial ownership of 8,448,158 shares, representing 9.8% of Heartflow, Inc.'s common stock as of June 30, 2026.

Summary

• BCLS Fund III Investments, LP, through its associated entities, holds a significant ownership stake in Heartflow, Inc.
• As of June 30, 2026, the Reporting Person beneficially owned 8,448,158 shares of Heartflow, Inc. common stock.
• This holding represents approximately 9.8% of the outstanding common stock.
• The percentage is based on 86,240,828 shares outstanding as of April 30, 2026, as per Heartflow's Form 10-Q filed on May 14, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as neutral to slightly positive, reflecting a significant but stable ownership stake without immediate indications of aggressive buying or selling.

Positives

• BCLS Fund III Investments, LP maintains a substantial 9.8% ownership in Heartflow, Inc., indicating continued confidence or strategic interest.
• The filing clearly delineates the ownership structure and shared voting/dispositive power among the Bain Capital Life Sciences Entities.

Negatives

• The filing indicates zero sole voting power and zero sole dispositive power for the Reporting Person, suggesting reliance on shared control.
• No new information regarding the company's performance or future strategy is provided, as this is a Schedule 13G filing focused on ownership.

Risks

• Potential for future changes in ownership percentage by BCLS Fund III Investments, LP, which could impact market dynamics.
• The reliance on shared voting and dispositive power could introduce complexities in decision-making if disagreements arise among the Bain Capital Life Sciences Entities.

Future Outlook

This filing is a Schedule 13G, which reports beneficial ownership and does not contain forward-looking statements or company guidance.

Industry Context

StockSavvy.ai notes that significant stakes held by investment firms like Bain Capital Life Sciences in healthcare technology companies like Heartflow are common, reflecting active investment in the sector. This filing primarily serves to update regulatory bodies on ownership levels.

Stakeholder Impact

• Shareholders: The continued significant stake by BCLS Fund III Investments, LP may be viewed positively, suggesting stability, but also indicates a large block holder whose future actions could influence share price.
• Creditors: No direct impact mentioned, but a stable major shareholder can imply a more stable corporate environment.
• Employees: Indirect impact through potential long-term strategic direction influenced by major shareholders.

Next Steps

• Monitor future filings from BCLS Fund III Investments, LP for any changes in their ownership stake in Heartflow, Inc.
• Observe Heartflow, Inc.'s subsequent financial reports and strategic announcements for company performance updates.

Key Dates

Keywords

Heartflow, BCLS Fund III Investments, Bain Capital Life Sciences, Schedule 13G, Ownership Stake, Common Stock, Beneficial Ownership, SEC Filing